IL2 treatment for cancer: from biology to gene therapy.

In this review we shall discuss the biological rationale and the clinical findings obtained using Interleukin 2 (IL2)-based immunotherapy in the management of cancer patients. Objective and long-lived clinical responses have been documented in a proportion of cases, particularly renal cell carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Foa, R., Guarini, A., Gansbacher, B.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978061/
https://www.ncbi.nlm.nih.gov/pubmed/1457368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1978061/
https://www.ncbi.nlm.nih.gov/pubmed/1457368

Ejemplares similares